COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.

Condition:   AnemiaInterventions:   Drug: darbepoetin alfa;   Drug: epoetin beta [NeoRecormon]Sponsor:   Hoffmann-La RocheCompleted - verified May 2015

Source: ClinicalTrials.gov - September 15, 2006 Category: Research Source Type: clinical trials